Zentiva is a major European pharmaceutical manufacturer with production sites in Prague (Czech Republic) and Bucharest (Romania), delivering essential medicines to more than 100 million patients across Europe each year. As a company focused on affordable, off-patent and critical medicines, we are committed to strengthening Europes health security and supply chain resilience.
ZGS
Zentiva Group, a.s.
Company · Czechia · EU Transparency Register 888725551808-41
2
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1210 companies & groups on this site, they rank #786 by legislative files engaged, a count of participation, not a measure of influence.
0.8
declared lobbying FTE
self-declared
€50K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2023
in the register since
Declares membership of
- Medicines for Europe - https://www.medicinesforeurope.com/
- BusinessEurope ASGroup - https://www.businesseurope.eu
- British Generic Manufacturers Association Limited (Medicines UK), United Kingdom
- The British Oncology Pharmacy Association, United Kingdom
- GEMME – GEnérique Même MEdicament, France
- MTÜ Ravimitootjate Liit, Estonia
- Latvijas Patentbrīvo Medikamentu Asociācija, Latvia
- Vaistų gamintojų asociacija (VGA), Lithuania
- Föreningen för Generiska läkemedel och Biosimilarer (FGL), Sweden
- Industriforeningen for Generiske og Biosimilære Lægemidler, Denmark
- Egualia – Industrie Farmaci Accessibili, Italy
- Unione Italiana Food, Italy
- and 23 more
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Companies & groups
- Registered as
- Zentiva Group a.s. (Zentiva)
- Head office
- Praha 10, Czech republic
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Zentiva in PolicySpeak: request access →
Work at Zentiva Group, a.s.? so we know who speaks for it.
Their record over time
Zentiva Group, a.s. filed 2 positions between 26 Jan 2026 and 13 May 2026, across 2 of the 665 legislative files tracked here.
What they argued
Zentiva is a major European pharmaceutical manufacturer with production sites in Prague (Czech Republic) and Bucharest (Romania), delivering essential medicines to more than 100million patients across Europe each year. As a company focused on affordable, offpatent and critical medicines, we are committed to strengthening Europes health security and supply chain resilience.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Zentiva Group, a.s. next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 50.
Is this your organization?
Everything on this page comes from Zentiva Group, a.s.’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.